Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             51 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A systematic survey identified methodological issues in studies estimating anchor-based minimal important differences in patient-reported outcomes Wang, Yuting
142 C p. 144-151
 artikel
2 Believing in black boxes: machine learning for healthcare does not need explainability to be evidence-based McCoy, Liam G.
142 C p. 252-257
 artikel
3 BNT162b2 vaccine effectiveness was marginally affected by the SARS-CoV-2 beta variant in fully vaccinated individuals Mor, Orna
142 C p. 38-44
 artikel
4 Causal analyses of existing databases: the importance of understanding what can be achieved with your data before analysis (commentary on Hernán) Morris, Tim P.
142 C p. 261-263
 artikel
5 Challenges of evidence synthesis during the 2020 COVID pandemic: a scoping review Khalil, Hanan
142 C p. 10-18
 artikel
6 Change in healthcare during Covid-19 pandemic was assessed through observational designs Corrao, Giovanni
142 C p. 45-53
 artikel
7 Commentary on controversy and debate 4 paper series: Questionable utility of the relative risk in clinical research Wells, George A.
142 C p. 268-270
 artikel
8 Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 1: A call for change to practice Doi, Suhail A.
142 C p. 271-279
 artikel
9 Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 2: Is the Odds Ratio “portable” in meta-analysis? Time to consider bivariate generalized linear mixed model Xiao, Mengli
142 C p. 280-287
 artikel
10 Controversy and Debate : Questionable utility of the relative risk in clinical research: Paper 4 :Odds Ratios are far from “portable” — A call to use realistic models for effect variation in meta-analysis Xiao, Mengli
142 C p. 294-304
 artikel
11 Editorial Board
142 C p. IFC
 artikel
12 Editors' Choice: February 2022 Tovey, David
142 C p. A6-A7
 artikel
13 Estimates of minimal clinically important improvments vary with the responsiveness of the sample Ward, Michael M.
142 C p. 110-118
 artikel
14 Estimating total morbidity burden of COVID-19: relative importance of death and disability Smith, Maia P.
142 C p. 54-59
 artikel
15 European non-commercial sponsors showed substantial variation in results reporting to the EU trial registry Dal-Ré, Rafael
142 C p. 161-170
 artikel
16 Extensive variability of work participation outcomes measured in randomized controlled trials: a systematic review Ravinskaya, Margarita
142 C p. 60-99
 artikel
17 Feasibility of national living guideline methods: The Australian Stroke Guidelines Hill, Kelvin
142 C p. 184-193
 artikel
18 GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines Cuello-Garcia, Carlos A.
142 C p. 200-208
 artikel
19 Guidelines developed under pressure. The case of the COVID-19 low-quality “rapid” guidelines and potential solutions Florez, Ivan D.
142 C p. 194-199
 artikel
20 International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review Amer, Yasser S.
142 C p. 333-370
 artikel
21 Interrater reliability of ROB2 – an alternative measure and way of categorization Loef, Martin
142 C p. 326-327
 artikel
22 Kappa and AC1/2 statistics: beyond the paradox Minozzi, Silvia
142 C p. 328-329
 artikel
23 Let's end “real-world evidence” terminology usage: A study should be identified by its design Pacheco, Rafael Leite
142 C p. 249-251
 artikel
24 Methods used to select results to include in meta-analyses of nutrition research: A meta-research study Kanukula, Raju
142 C p. 171-183
 artikel
25 Missing data is poorly handled and reported in prediction model studies using machine learning: a literature review Nijman, SWJ
142 C p. 218-229
 artikel
26 Missing trials in drug regulatory dossiers may have good reasons, but should be predefined and transparent Leufkens, Hubert G.
142 C p. 258-260
 artikel
27 Mortality prediction in intensive care units including premorbid functional status improved performance and internal validity Moser, André
142 C p. 230-241
 artikel
28 Prediction models: stepwise development and simultaneous validation is a step back Heinze, Georg
142 C p. 330-331
 artikel
29 Reassembling the fragility index: a demonstration of statistical reasoning Baer, Benjamin R.
142 C p. 317-318
 artikel
30 Replicability in the context of systematic reviews: A call for a framework with considerations regarding duplication, overlap, and intentionality Puljak, Livia
142 C p. 313-314
 artikel
31 Resource use during systematic review production varies widely: a scoping review: authors’ reply Nussbaumer-Streit, B
142 C p. 321-322
 artikel
32 Resource use during systematic review production varies widely: a scoping review: response to Nussbaumer-Streit et al. Morales-Plaza, Cristhian D.
142 C p. 319-320
 artikel
33 Rethinking Table 1 Horwitz, Ralph I.
142 C p. 242-245
 artikel
34 Sequential multiple assignment randomized trial studies should report all key components: a systematic review Bigirumurame, Theophile
142 C p. 152-160
 artikel
35 Sex and Gender Appraisal Tool-Systematic Reviews-2 and Participation-To-Prevalence Ratio assessed to whom the evidence applies in sepsis reviews Antequera, A
142 C p. 119-132
 artikel
36 Small differences in EQ-5D-5L health utility scores were interpreted differently between and within respondents McClure, Nathan S.
142 C p. 133-143
 artikel
37 Stepwise model development and simultaneous validation to keep up with clinically relevant and rapidly changing diagnostic techniques Haalboom, M
142 C p. 332
 artikel
38 Table of Contents
142 C p. A2-A5
 artikel
39 The certainty of the evidence in oral health has not improved according to GRADE: a meta-epidemiological study Seehra, Jadbinder
142 C p. 29-37
 artikel
40 The difference between evidence-based medicine, evidence-based (clinical) practice, and evidence-based health care Puljak, Livia
142 C p. 311-312
 artikel
41 The fragility index should not be used for sample size calculations in clinical trials Potter, Gail E
142 C p. 315-316
 artikel
42 The inclusion of outcomes in search strategies for Cochrane Reviews: authors’ reply Tsujimoto, Yasushi
142 C p. 324-325
 artikel
43 The inclusion of outcomes in search strategies for Cochrane Reviews: response to Tsujimoto et al Verbeek, Jos
142 C p. 323
 artikel
44 The methodological quality was low and conclusions discordant for meta-analyses comparing proximal humerus fracture treatments: a meta-epidemiological study Sandau, Nicolai
142 C p. 100-109
 artikel
45 The methodology of a “living” COVID-19 registry development in a clinical context Arienti, Chiara
142 C p. 209-217
 artikel
46 The Odds Ratio is “portable” across baseline risk but not the Relative Risk: Time to do away with the log link in binomial regression Doi, Suhail A.
142 C p. 288-293
 artikel
47 The use of GRADE approach in Cochrane reviews of TCM was insufficient: a cross-sectional survey Wang, Qi
142 C p. 1-9
 artikel
48 Transparency: A central principle underpinning trustworthy guidelines Ford, Nathan
142 C p. 246-248
 artikel
49 Tutorial on directed acyclic graphs Digitale, Jean C.
142 C p. 264-267
 artikel
50 Use of core outcome sets was low in clinical trials published in major medical journals Matvienko-Sikar, Karen
142 C p. 19-28
 artikel
51 Using a stepwise approach to simultaneously develop and validate machine learning based prediction models Haalboom, M.
142 C p. 305-310
 artikel
                             51 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland